Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 240Rectal Neoplasms 93Colonic Neoplasms 91Pancreatic Neoplasms 87Stomach Neoplasms 68Neoplasm Metastasis 47Esophageal Neoplasms 41Neoplasms 36Small Cell Lung Carcinoma 29Lung Neoplasms 29Neuroblastoma 28Glioblastoma 28Glioma 27Brain Neoplasms 26Carcinoma, Non-Small-Cell Lung 22Adenocarcinoma Of Esophagus 20Gliosarcoma 19Breast Neoplasms 18Astrocytoma 18Esophageal Squamous Cell Carcinoma 17Central Nervous System Neoplasms 17Unspecified Adult Solid Tumor, Protocol Specific 16Oligodendroglioma 13Adenocarcinoma 13Rhabdomyosarcoma 10Gastrointestinal Neoplasms 10Biliary Tract Neoplasms 10Sarcoma 9Gallbladder Neoplasms 9Cholangiocarcinoma 9

Interventions

Gemcitabine 5Irinotecan 2Albumin-Bound Paclitaxel 2regorafenib 1pembrolizumab 1olaparib 1ibrutinib 1Tetrahydrouridine 1Telemedicine 1Taxes 1Practice Guidelines as Topic 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Fluorouracil 1Erlotinib Hydrochloride 1Docetaxel 1Decitabine 1Counseling 1Cisplatin 1Capecitabine 1BKT140 14-fluorobenzoyl-TN-14003 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Metastatic Pancreatic Adenocarcinoma × Irinotecan × Clear all
NCT02324543 2023-07-21

Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
47 enrolled 22 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01729481 2017-07-19

ML22774

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
150 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡